No products in the cart.
Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection by more than 50%. 2....
Canadian Syncope Risk Score demonstrates international external validation
1. The Canadian Syncope Risk Score was superior when compared to the Osservatorio Epidemiologico della Sincope nel Lazio (OESIL) score...
Dapagliflozin efficacious and safe in treating heart failure
1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of frailty status. 2. Dapagliflozin improved quality...
Nasal high-flow therapy improves likelihood of neonatal intubation
1. In infants undergoing endotracheal intubation, nasal high-flow therapy improved the likelihood of successful intubation on the first attempt. 2....
Early ivermectin treatment does not lower Covid-19 related hospitalizations
1. Ivermectin treatment did not lower the incidence of medical admission to a hospital due to the progression of Covid-19....
Time restricted eating not more beneficial than daily calorie restriction
1. For patients with obesity, time-restricted eating was not more significantly beneficial in reducing body weight or body fat than...
Nonfatal firearm injuries associated with increased psychiatric disorders and substance use disorders
1. Survivors of nonfatal firearm injuries experienced an increase in psychiatric disorders, substance use disorders, pain diagnoses, and worsening mental...
Ivosidenib and azacitidine provide significant benefits in IDH1-mutated acute myeloid leukemia
1. Compared to placebo and azacytidine, the combination of ivosidenib and azacitidine demonstrated significant clinical benefit for IDH1-mutated acute myeloid...
Widespread population immunity of Covid-19 observed in South Africa before Omicron wave
1. Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng province, South Africa, before the omicron wave. 2. Epidemiologic data demonstrated...
Rilzabrutinib demonstrates rapid and durable clinical activity for immune thrombocytopenia
1. Rilzabrutinib was active and 400mg twice daily was identified as the dose for further testing with low-level toxic effects....
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.